(Q72871755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Ubenimex in the treatment of acute nonlymphocytic leukemia in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

A Urabe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

Y Mutoh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

H Mizoguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

F Takaku

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

N Ogawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 August 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

63-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine

29 October 2019

cites work

1 reference

12 December 2020

Toxicological studies on bestatin. III. Chronic toxicity test and recovery study in beagle dogs

1 reference

12 December 2020

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

12 December 2020

Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function

1 reference

12 December 2020

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient

1 reference

12 December 2020

Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults

1 reference

12 December 2020

Enhancing effect of ubenimex (bestatin) on proliferation and differentiation of hematopoietic progenitor cells, and the suppressive effect on proliferation of leukemic cell lines via peptidase regulation

1 reference

12 December 2020

Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes

1 reference

12 December 2020

Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia.

1 reference

12 December 2020

The role of immunotherapy in acute myelogenous leukemia

1 reference

12 December 2020

Review of ubenimex (Bestatin): clinical research

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01788128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8347731%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference